New St. Luke's Roosevelt Research Grants Announced

8/7/2013

Leading-edge medical studies are taking place in St. Luke’s and Roosevelt Hospitals’ Department of Medicine. For example, professionals in our department have recently received funding to carry out various innovative investigations, including the following:

Study Name: Time and Nutrient Dependent Dynamics of Satiation: A Pilot Study
Principal Investigator: Harry R. Kissileff, PhD
Sponsor: The University of Alabama at Birmingham

Study Name: ISCHEMIA Trial
Principal Investigator: Seth Uretsky, MD
Sponsor: National Heart, Lung, and Blood Institute/New York University

Study Name: Random Study to Access the Safety and Efficacy of Plecanitide in PTs with Irritable Bowel Syndrome, with Constipation
Principal Investigator: Jean Saleh, MD
Sponsor: Synergy Pharmaceuticals

Study Name: Health Care Challenge—Transition Clinic Network: Linking High Risk Medicaid Patients
Principal Investigator: Victoria Sharp, MD
Sponsor: City College of San Francisco

Study Name: Grossbard-PCI32765MCL2001
Principal Investigator: Michael Grossbard, MD
Sponsor: Janssen Research and Development, LLC

Study Name: HP VLU Large Ulcer Trial,
Principal Investigator: John Lantis, MD
Sponsor: HealthPoint Biotherapeutics

Study Name: Harvest Trial
Principal Investigator: John Lantis, MD
Sponsor: Harvest Technologies

Study Name: Sanuwave Study
Principal Investigator: John Lantis, MD
Sponsor: Sanuwave

Study Name: HP VLU Trial
Principal Investigator: John Lantis, MD
Sponsor: HealthPoint Biotherapeutics

Study Name: Amitriptyline and Topiramate in the Prevention of Childhood Migraine
Principal Investigator: Joshua Cohen, MD
Sponsor: U.S. Department of Health and Human Services/National Institutes of Health/National Institute of Neurological Disorders and Stroke

Study Name:
Intervention to Increase Timely Initiation of HAART Amount Those Who Delay/Decline
Principal Investigator: Hannah Wolfe, MD
Sponsor: National Institutes of Health

Back to News Listing